Frontlight ResearchEarly access
Pancreatic cancer trials in China
326 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peoplemFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 30
- Run by
- Fudan University
See details and how to joinNCT06249321 - Phase 3Taking peopleRadiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 210
- Run by
- Fudan University
See details and how to joinNCT06250972 - Phase 2Taking peopleA Study of GnP RegimenCombined With Serplulimab and Stereotactic Body Radiation Therapy as First-line Treatment for Locally Advanced Pancreatic Cancer
- Where
- Chengdu
- Age
- 18 years to 75 years
- People
- 23
- Run by
- West China Hospital
See details and how to joinNCT07101679 - No phaseTaking peopleConstruction and Clinical Application of the Immune Map of Pancreatic Cancer Evolution
- Where
- Hangzhou
- Age
- 18 years to 80 years
- People
- 1,500
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07034339 - Phase 2Taking peopleA Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 65
- Run by
- Fudan University
See details and how to joinNCT05969171 - No phaseTaking peopleA Cohort Study on ctDNA MRD in Neoadjuvant Therapy for Pancreatic Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 119
- Run by
- Ruijin Hospital
See details and how to joinNCT07080021 - No phaseNot yet taking people in ChinaInverted-Ω Anastomosis in Laparoscopic Duodenum-Preserving Pancreatic Head Resection or Laparoscopic Central Pancreatectomy
- Where
- Chengdu
- Age
- 18 years to 75 years
- People
- 20
- Run by
- West China Hospital
See details and how to joinNCT07087392 - No phaseTaking peopleAdjuvant Pancreatic Therapy Guided by MRD
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 856
- Run by
- Ruijin Hospital
See details and how to joinNCT06966440 - Phase 1/2Taking peopleMesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer
- Where
- Beijing
- Age
- 21 years to 90 years
- People
- 60
- Run by
- Essen Biotech
See details and how to joinNCT07066995 - No phaseTaking peopleClinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 in the Treatment of Pancreatic Cancer With Liver Metastasis
- Where
- Shanghai
- Age
- 18 years to 70 years
- People
- 12
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06307080 - No phaseTaking peopleCtDNA-guided Maintenance Therapy in Pancreatic Cancer
- Where
- Nanjing
- Age
- 18 years and over
- People
- 70
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07054879 - Phase 1/2Taking peopleClinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
- Where
- Shanghai
- Age
- 18 years to 70 years
- People
- 40
- Run by
- Shanghai Public Health Clinical Center
See details and how to joinNCT03093688 - No phaseTaking peoplePancreatic Cancer and Diabetes Mellitus
- Where
- Shanghai
- Age
- 18 years and over
- People
- 150
- Run by
- Shanghai Changzheng Hospital
See details and how to joinNCT06585072 - No phaseNot yet taking people in China22G-Adapt vs 22G-Franseen Needle Biopsy in EUS-Guided Tissue Acquisition of Solid Lesions
- Where
- Wuhan
- Age
- 18 years to 85 years
- People
- 576
- Run by
- Huazhong University of Science and Technology
See details and how to joinNCT07012694 - No phaseTaking peopleMSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer
- Where
- Shanghai
- People
- 1,000
- Run by
- Yingbin Liu, MD, PhD, FACS
See details and how to joinNCT07045571 - No phaseNot yet taking people in ChinaA Real-world Study of Liposomal Irinotecan (Onivyde)-Based Therapy in Patients With Locally Advanced/Metastatic Pancreatic Cancer in China
- Where
- Shanghai
- Age
- 18 years and over
- People
- 40
- Run by
- RenJi Hospital
See details and how to joinNCT07026123 - No phaseTaking peopleBile Omics for Diagnosing Indeterminate Biliary Strictures
- Where
- Shanghai
- Age
- 18 years to 90 years
- People
- 260
- Run by
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07007832 - No phaseTaking peopleThe Characteristics of Oral Microbiota in Chronic Pancreatitis and Autoimmune Pancreatitis
- Where
- Shanghai
- Age
- 18 years and over
- People
- 360
- Run by
- Ruijin Hospital
See details and how to joinNCT07015580 - No phaseNot yet taking people in ChinaTherapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies
- Where
- Xi'an
- Age
- 18 years to 80 years
- People
- 20
- Run by
- Xijing Hospital
See details and how to joinNCT07014254 - Phase 1Taking peopleA Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 318
- Run by
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT05740956 - Phase 1Taking peopleCAR-NK Cells (CL-NK-001) in Pancreatic Cancer
- Where
- Shanghai
- Age
- 18 years to 70 years
- People
- 30
- Run by
- Changhai Hospital
See details and how to joinNCT06816823 - Phase 2Taking peopleClinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer
- Where
- Wuhan
- Age
- 18 years and over
- People
- 25
- Run by
- Liu Huang
See details and how to joinNCT06199895 - No phaseTaking peopleEnucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery
- Where
- Hangzhou
- Age
- 14 years to 70 years
- People
- 30
- Run by
- Zhejiang University
See details and how to joinNCT06164769 - Phase 2Taking peopleA Study on Ivonescimab Plus Chemotherapy as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer
- Where
- Tianjin
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06944106 - Phase 2Taking peoplemFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients
- Where
- Guangzhou
- Age
- 18 years to 79 years
- People
- 80
- Run by
- Sun Yat-sen University
See details and how to joinNCT04084496